RadNet, Inc. (RDNT) Stock Price & Analysis
RadNet, Inc. (RDNT) closed at USD 70.41 on Thursday, October 15, 2026, up 1.81% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 69.16; the Oct 15, 2026 session ranged USD 69.08–70.81 on volume of 461,298 shares. Market capitalization is $5.54B, with a 52-week range of USD 50.82–85.84 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/RDNT.md
Key facts (RDNT)
- Last four reported quarters (through Jun 30, 2026): revenue $2.27B, net income -$21.1M (-0.9% margin) (SEC filings).
- 2 of 80 tracked superinvestors hold RDNT (13F, Q2 2026): 0 new, 1 added, 0 reduced, 1 unchanged.
- Analysts: Buy (mean 1.75 on a 1–5 scale) (8 analysts), mean target USD 94.63 (range 79–105).
- Total return with dividends: 1Y -9.0% vs S&P 500 +18.1%; 5Y +144.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD 0.22, revenue estimate $639M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (RDNT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.32B | $1.43B | $1.62B | $1.83B | $2.04B | $2.27B |
| Operating income | $82.6M | $46.4M | $98.7M | $105M | $62.0M | $70.8M |
| Net income | $24.7M | $10.7M | $3.0M | $2.8M | -$18.7M | -$21.1M |
| EPS (diluted) | $0.46 | $0.17 | $0.05 | $0.04 | -$0.25 | — |
| Operating margin | 6.3% | 3.2% | 6.1% | 5.7% | 3.0% | 3.1% |
| Net margin | 1.9% | 0.7% | 0.2% | 0.2% | -0.9% | -0.9% |
| Revenue growth | +22.7% | +8.7% | +13.0% | +13.2% | +11.5% | — |
| Cash + short-term investments | $135M | $128M | $343M | $740M | $767M | — |
| Total debt | $755M | $852M | $830M | $1.02B | $1.09B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (RDNT)
P/S 2.4x · EV/EBITDA 25.4x · EV/Sales 2.7x · P/B 5.1x · Earnings yield -0.38% · Net debt $606M · EV $6.15B
P/E at fiscal year-ends: Dec 2024 1869.5x, Dec 2023 738.6x.
Superinvestors (SEC 13F-HR, Q2 2026) (RDNT)
2 of 80 tracked investors hold RDNT. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Mairs & Power | Mairs & Power Funds | 0.08% | $8.2M | Unchanged |
| First Eagle Investment | First Eagle Investment Management | 0.02% | $12.0M | Added +107.2% |
Analysts (RDNT)
Consensus Buy (mean 1.75 on a 1–5 scale), 8 analysts; mean target USD 94.63 (low 79, high 105).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-28 | Barclays | Target raised | Overweight | $65 → $79 |
| 2026-08-11 | Truist Securities | Target raised | Buy | $90 → $94 |
Total return (dividends reinvested) (RDNT)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -9.0% | +144.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -9.1% | +19.5% |
| Volatility (annualized) | 42.1% | 42.5% |
| Max drawdown | -38.6% (Nov 2025→Jun 2026) | -52.0% (Nov 2021→Nov 2022) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 70.41 |
|---|---|
| Change | ▲ 1.81% (up) |
| Previous Close | USD 69.16 |
| Open | USD 70.12 |
| Day Range | USD 69.08 – 70.81 |
| 52-Week Range | USD 50.82 – 85.84 |
| Volume | 461,298 shares |
| Market Cap | $5.54B |
| Exchange | NGM |
Technical Analysis (RDNT)
Nexqual's technical model rates RDNT "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.88 (neutral) |
| vs SMA50 | Below (USD 73.48) |
| MACD | -0.79 (negative) |
Analyst Ratings (RDNT)
Wall Street analysts rate RDNT "Buy" based on 8 analysts, with a mean price target of USD 94.63 (range USD 79–105), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 94.63 |
| High Target | USD 105 |
| Low Target | USD 79 |
| Buy / Hold / Sell | 8 / 0 / 0 |
Earnings (RDNT)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0.22 |
| Revenue Estimate | $639.21M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.29 vs est 0.2 ▲ beat |
| 2026-03-31 | USD -0.28 vs est -0.19 ▼ miss |
| 2025-12-31 | USD 0.23 vs est 0.2 ▲ beat |
| 2025-09-30 | USD 0.2 vs est 0.23 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (RDNT)
| Total Revenue | $2.27B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +25.00% |
| Gross Margin | +17.28% |
| Operating Margin | +7.89% |
| Profit Margin | -0.93% |
| ROE | +1.50% |
| Debt / Equity | 1.57 |
| Current Ratio | 1.48 |
| Total Cash | $726.27M |
| Total Debt | $2.18B |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (RDNT)
Nexqual rates RadNet, Inc.'s overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 17%, operating 8% |
| Balance Sheet | Weak — $726M cash vs $2.18B debt |
| Cash Flow | Solid — Operating cash flow $299M (FY ended Dec 2025, 10-K) |
| Efficiency | Weak — ROE 1%, ROA 1.7% |
Ownership (RDNT)
| Insider Ownership | +9.96% |
|---|---|
| Institutional Ownership | +105.58% |
| Shares Outstanding | 78.70M |
| Float | 65.76M |
| Short % of Float | +14.07% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (RDNT)
RadNet, Inc. is led by Howard G. Berger (age 79), Chairman, President & CEO, per Nexqual as of October 16, 2026 at 05:21 UTC.
| Chairman, President & CEO | Howard G. Berger (age 79) |
|---|---|
| Executive VP & CFO | Mark D. Stolper (age 54) |
| Executive VP & COO | Mital Patel (age 39) |
| President & CEO of Western Operations | Norman R. Hames (age 69) |
| President & CEO of Eastern Operations | Stephen M. Forthuber (age 64) |
Major Backers & Investors (RDNT)
Notable institutional backers of RadNet, Inc. include RTW Investments LP, Price (T.Rowe) Associates Inc, Beck, Mack & Oliver LLC, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| RTW Investments LP | 6.16% |
| Price (T.Rowe) Associates Inc | 5.72% |
| Beck, Mack & Oliver LLC | 4.02% |
| American Century Companies Inc | 3.31% |
| T. Rowe Price | 2.23% |
| Invesco | 2.09% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 20.69% |
| Vanguard Group | 15.34% |
| State Street | 3.61% |
| Geode Capital | 2.36% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHC | Sotera Health Company | USD 18.07 | ▼ 0.77% |
| GRAL | GRAIL, Inc. | USD 135.46 | ▼ 3.48% |
| BLLN | BillionToOne, Inc. | USD 102.73 | ▲ 8.78% |
| ADPT | Adaptive Biotechnologies Corpor | USD 25.58 | ▲ 1.19% |
| VCYT | Veracyte, Inc. | USD 44.39 | ▲ 2.97% |
| CDNA | CareDx, Inc. | USD 66.68 | ▲ 1.9% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt